(Q51386243)

English

Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent?

scientific article published in August 2000

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

title

Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

1 reference

W Dean

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

language of work or name

English

0 references

publication date

1 August 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

published in

Mayo Clin Proc

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

volume

75

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

page(s)

872-873

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

Identifiers

DOI

10.4065/75.8.872

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

PubMed publication ID

10943250

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10943250

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/10943250

ResearchGate publication ID

12378014

0 references

(Q51386243)

Physostigmine treatment of gamma-hydroxybutyric acid overdose: appropriate or inappropriate use of a reversal agent?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)